
Keywords: AC; adenyl cyclase; AD; Alzheimer's disease; 2-AG; 2-arachidonoylglycerol; ABHD6; α,β hydrolase 6; AEA; arachidonylethanolamide/anandamide; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; cAMP; cyclic adenosine monophosphate; CBD; cannabid